Zika virus is transmitted to people primarily through the bite of an infected Aedes species mosquito, the mosquitoes that alos spread dengue and chikungunya viruses.

NIH to Monitor Zika Exposure Among U.S. Olympic Committee Personnel

Some athletes, coaches, and other USOC staffers attending the 2016 Summer Olympics and Paralympics in Brazil next month will be monitored in a study funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Researchers supported by the National Institutes of Health will be monitoring Zika virus exposure among some of the athletes, coaches, and other U.S. Olympic Committee (USOC) staffers who are attending the 2016 Summer Olympics and Paralympics in Brazil next month. Their study, funded by NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and led by Dr. Carrie L. Byington, M.D., from the University of Utah, Salt Lake City, aims to better understand how the virus persists in the body and to identify potential factors that influence the course of infection.

Some well-known athletes have declined to participate in the 2016 Summer Olympics, which will take place Aug. 5-21 in Rio de Janeiro, because of concerns about the virus. The Paralympic Games are scheduled for Sept. 7-18 in Rio.

"Zika virus infection poses many unknown risks, especially to those of reproductive age," said Dr. Catherine Y. Spong, M.D., acting director of NICHD. "Monitoring the health and reproductive outcomes of members of the U.S. Olympic team offers a unique opportunity to answer important questions and help address an ongoing public health emergency."

NIH reported that USOC established an Infectious Disease Advisory Group chaired by Byington to help prepare the U.S. Olympic team for travel to Brazil, which is the epicenter of the Zika virus outbreak in the Americas. She proposed the project, which aims to enroll at least 1,000 men and women, in response to an NIH announcement to expedite review and funding for Zika-related research projects. "We partnered with the USOC to improve knowledge of the dynamics of Zika infection, so that we can better protect the health of athletes and staff who will participate in the 2016 Games," Byington said. "This ongoing relationship also opens avenues for long-term research that promises to benefit not only the Americas, but also other regions facing the emergence of the virus."

The current study seeks to determine the incidence of Zika virus infection, identify potential risk factors for infection, detect where the virus persists in the body (blood, semen, vaginal secretions or saliva), evaluate how long the virus remains in these fluids, and study the reproductive outcomes of Zika-infected participants for up to one year.

"To prepare, USOC and the University of Utah conducted a pilot study in March and April 2016. The study was fully enrolled in two days and included 150 participants. Notably, one-third of the pilot group indicated that they or their partner planned to become pregnant within 12 months of the Olympic Games. Participants in the current study will complete health surveys and provide samples of bodily fluids for the detection of Zika and similar flaviviruses, such as dengue. Zika virus infection typically does not cause symptoms in adults, so routine sampling will detect asymptomatic infections and help shed light on symptomatic versus asymptomatic infections. Zika virus testing kits and training on how to use the tests will be provided by the U.S. Centers for Disease Control and Prevention," NIH reported. "Before traveling to Brazil, all USOC staff, including athletes and coaches, will be briefed on a number of items, including the Zika outbreak. IDAG will provide educational materials to athletes and staff and answer questions. During this time, the NIH-funded researchers will present the study and enroll as well as consent USOC staff who are interested in participating. Approximately 3,000 USOC staff members are expected to travel to Brazil. In addition, spouses or sexual partners who are traveling to Brazil may be eligible to participate."

Product Showcase

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" 3

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. 3

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! 3

Featured